Bellicum Pharmaceuticals, Inc Earning Date (BLCM)

USA |NASDAQ |USD

BLCM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2022 Sep 2022 - - $0.07
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2022 Sep 2022 - - $5.00M

Bellicum Pharmaceuticals, Inc's next earnings date is Wednesday, Nov 2, 2022 for the fiscal quarter ending Sep 2022.

BLCM Earnings Date & History Chart

BLCM Earnings & Revenue Forecast

BLCM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 0 $0.00 $0.00 $0.00

BLCM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.93 $-2.93 $-2.93

BLCM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

BLCM Earnings Date & Revenue History

BLCM Earnings History

|
Show More
Show More

BLCM Revenue History

|
Show More
Show More

Bellicum Pharmaceuticals, Inc Next Earnings Date & Report

BLCM Next Earnings Date & Report Preview: Sep 2022 (FQ)

BLCM's next earnings date is Wednesday, Nov 2, 2022 for the fiscal quarter ending Sep 30, 2022.

Bellicum Pharmaceuticals, Inc Previous Earnings Dates & Reports

BLCM Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Bellicum Pharmaceuticals, Inc's previous earnings date was Aug 10, 2022 for its fiscal quarter ended Jun 30, 2022.

BLCM Previous Earnings Date & Report Recap: Dec 2021 (FY)

Bellicum Pharmaceuticals, Inc's previous annual earnings date was Mar 24, 2022 for its fiscal year ended Dec 31, 2021.

BLCM's earnings per share (EPS) was $-1.16, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2020) by -82.58%.

Revenues were $6.20K.

The company reported a net income of $-9.71K.

Bellicum Pharmaceuticals, Inc reported a free cash flow of $-22.21K for its fiscal year, compared to $-55.38M a year ago.